AGC Biologics has completed a new manufacturing building at its Copenhagen campus. The expansion doubles the site’s single-use bioreactor capacity for mammalian services, allowing it to produce 150 more batches of drug product each year. The expansion adds 19,000 square meters of space in an ultramodern building that houses a large manufacturing floor, expanded quality control and process development lab space, utilities to support all operations and prevent outages caused by natural disast...